Free Trial

Ambu A/S (OTCMKTS:AMBBY) Shares Gap Down - Time to Sell?

Ambu A/S logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • Shares gapped down from $11.00 to $10.65 on Wednesday and last traded at $10.65 on very low volume (501 shares), now trading below its 50‑day ($11.32) and 200‑day ($13.16) moving averages.
  • Fundamental snapshot: market cap ~$2.50B, P/E 34.35, low leverage (debt/equity 0.08) and healthy liquidity (current ratio 2.86); latest quarter showed $0.07 EPS on $242.85M revenue with an 8.86% net margin.
  • Company profile: Denmark‑based medical device maker specializing in single‑use diagnostic and life‑support products, best known for disposable "Ambu bags," airway‑management devices and endoscopy systems.
  • MarketBeat previews the top five stocks to own by May 1st.

Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY - Get Free Report)'s stock price gapped down before the market opened on Wednesday . The stock had previously closed at $11.00, but opened at $10.65. Ambu A/S shares last traded at $10.65, with a volume of 501 shares changing hands.

Ambu A/S Price Performance

The company has a market cap of $2.50 billion, a price-to-earnings ratio of 34.35 and a beta of 1.25. The company has a current ratio of 2.86, a quick ratio of 1.67 and a debt-to-equity ratio of 0.08. The business has a 50-day moving average price of $11.32 and a 200 day moving average price of $13.16.

Ambu A/S (OTCMKTS:AMBBY - Get Free Report) last released its quarterly earnings data on Wednesday, February 4th. The company reported $0.07 earnings per share for the quarter. The business had revenue of $242.85 million during the quarter. Ambu A/S had a return on equity of 9.15% and a net margin of 8.86%.

Ambu A/S Company Profile

(Get Free Report)

Ambu A/S is a Denmark-based medical device company specializing in single-use diagnostic and life-supporting equipment for hospitals, clinics and emergency services. The company's core focus lies in developing products that enhance patient safety, streamline clinical workflows and reduce the risk of cross-contamination. Ambu's offerings span critical care solutions such as anesthesia and respiratory care devices, as well as advanced endoscopy systems for minimally invasive diagnostics and therapies.

Within its anesthesia and respiratory care segment, Ambu is known for its market-leading disposable resuscitators—commonly referred to as “Ambu bags”—as well as a range of airway management products, including laryngeal masks and endotracheal tubes.

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Ambu A/S Right Now?

Before you consider Ambu A/S, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ambu A/S wasn't on the list.

While Ambu A/S currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines